Used at increasing scale by top pharma companies
“At Sanofi, our drug discovery strategy is driven by precision medicine. We seek to describe diseases at the molecular and cellular level to understand the causes underpinning different patient responses to treatments, and to ultimately match the right medicine to the right patient. We are pleased to expand our collaboration with CytoReason and look forward to applying insights from this collaboration as we work to develop new treatments for patients with IBD.”
Emanuele de Rinaldis - Sanofi, Global Head of Target, Disease & Systems Biology
Explore the computed disease biology evidence behind your most important portfolio decisions
See how CytoReason generates computed disease biology evidence to help test scientific hypotheses
and answer the critical biological questions behind each portfolio decision.
Why CytoReason is uniquely able to generate
disease biology evidence
CytoReason combines human molecular and clinical data, computational disease biology, and scientific expertise to generate explainable disease biology evidence at scale.